Price target
7.200.000.00%
The 5 analysts offering 1 year price forecasts for GANX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to GANX in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GANX EPS for the last quarter is −0.17 USD despite the estimation of −0.21 USD. In the next quarter EPS is expected to reach −0.17 USD. Track more of Gain Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Gain Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Gain Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, GANX price target is 7.20 USD with a max estimate of 10.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile watch Gain Therapeutics, Inc. stock price chart and keep track of the current situation with GANX news and stock market news.
We've gathered opinions of 5 analysts rating GANX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.